SUMMARY The infrequency of multiple sclerosis in India may have genetic implications. We found (a) the HLA-A3 and HLA-B7 haplotypes amongst Indians to be lower than those reported in Caucasians, (b) no excess of HLA-A3 and HLA-B7 amongst our 27 multiple sclerosis patients compared to 330 controls; instead it was the reverse, (c) HLA-B12 as high as 74% in the "clinically definite" cases, against only 9% in controls, (d) a significant relative risk of MS amongst Indians with HLA-B12 haplotype. Attention is drawn to the higher incidence of MS amongst the small Parsee community and the high association of HLA-B12 in these patients.
The association between histocompatibility antigens and greater susceptibility to multiple sclerosis (MS) has been generally accepted. There is now good evidence that amongst Caucasians, the histocompatibility antigens HLA-A3 and HLA-B7, and more significantly the mixed culture lymphocyte determinant HLA-Dw2, occur substantially more often in patients with MS than in the population at large of the same area.1-6 It is noteworthy that population studies in Israel, Japan and Jordan have shown no excess of HLA-A3 and HLA-B7,6 7 although an association with a locally defined lalike antigen closely related to DRw4 and DRw7 has been found in Jordan. 6 8 We were interested in determining whether there would be any such association of HLA-antigens with MS patients in India, considering amongst other variable factors that the disease has a lower incidence in this country.9
Patients, materials and methods Twenty-seven patients seen by one of us (NHW) over the last 15 years could be recalled for the study. The diagnosis of MS was made clinically and the cases subclassified using the criteria of McDonald and Halliday.10 Visual evoked response and estimation of CSF immunoglobulins carried out in several of our cases, were not used to make the diagnosis. Nineteen patients were considered as "clinically definite" cases. They had multiple lesions in the nervous system and a remitting relapsing course of the disease with more than two episodes. The disease had been present for at least a year, and often for several years, the age at onset being 20 to 40 years. Among the rest, two were considered as "early probable or latent", two were "progressive probable", one was "progressive possible" and three were suspected cases. These patients were detected randomly from the usual ethnic mix seen by neurologists in clinical practice in Bombay. Normal controls (330) were also randomly drawn mostly from families in Bombay, who underwent tissue typing as a screening procedure for related donors in the kidney transplant programme at this hospital. These controls came from 100 families representative of the heterogenity of the Indian population. Fifty-seven sera representing different HLA antigens of the A, B and C series kindly donated by Professors JJ Van Rood and F Kissmeyer-Nielsen were used for tissue typing, employing the lymphocyte microtoxicity technique.' Results A striking finding among the patient population was that HLA-B12 occurred at a frequency in excess of what was found in the control population (table 1). Poser'3 has drawn special attention to the importance of a decreased incidence of certain histocompatibility antigens in MS, which suggests the possible existence of protective genetic factors. This negative correlation appears to exist for HLA-B12 in patients with MS reported from USA, Canada, Denmark, Norway, and Germany in contrast to the positive correlation in our patients.
In the present study, eight of the 27 patients of the whole series and six of the 19 "clinically definite" cases were Parsees. It is striking that nearly one third of the patients came from this small community (70,000 in a population of 7 
